Ferrer, the private international pharmaceutical company, is looking for new ideas and start-ups that can provide novel solutions in different areas
As part of the Health Revolution Congress (17th May, Barcelona), at Ferrer we are excited to launch an open innovation challenge in the space of Amyotrophic Lateral Sclerosis (ALS).
Through this challenge, Ferrer hopes to bring together cutting-edge digital solutions to address different challenges in the field of ALS. The goal is to drive innovation and find new ways to improve the lives of those living with this debilitating disease.
Ferrer is looking for start-ups that can provide novel solutions in, but not limited to, the areas of Remote Monitoring, Beyond the Pill – digital and tech solutions that can enhance the adherence and/or effectiveness of ALS treatment – and Care Pathway Innovation – digital and tech solutions that can improve the patient experience throughout the care pathway.
To participate in this challenge, start-ups must have a solution that has been validated in the market. We welcome innovative solutions from all corners of the globe.
Discover all information about this challenge here.
Ferrer is a private international pharmaceutical company with a growing focus on two main areas that include serious debilitating and rare or low prevalence diseases: pulmonary vascular and interstitial lung diseases and neurological disorders.
Ferrer’s purpose is to make a positive impact in society, guided by three strategic pillars: Great people, Liveable planet and Social justice. For Ferrer, the pharmaceutical business is not an end in itself, but a means to generate substantial social change.